## Staged Management of Graves' Disease: Antithyroid Drug Initiation **Key Point:** Beta-blockers provide symptomatic relief of adrenergic manifestations but do NOT reduce thyroid hormone levels. Antithyroid drugs (PTU or methimazole) must be added to inhibit hormone synthesis and achieve euthyroidism. ### Pathophysiology of Graves' Disease Graves' disease is caused by TSH receptor antibodies (TRAb) that stimulate thyroid hormone synthesis and release. Beta-blockers block the peripheral effects of excess thyroid hormone (tachycardia, tremor, anxiety) but do not lower hormone levels. ### Three-Phase Management Strategy ```mermaid flowchart TD A[Graves' disease diagnosed]:::outcome --> B[Phase 1: Symptom control]:::action B --> C[Beta-blocker: propranolol 40-80 mg BD]:::action C --> D[Phase 2: Hormone synthesis inhibition]:::action D --> E{PTU or Methimazole?}:::decision E -->|First-line in most| F[Methimazole 30-40 mg daily]:::action E -->|Pregnancy/1st trimester| G[PTU 300-450 mg daily]:::action F --> H[Monitor TSH, free T4 every 4-6 weeks]:::action G --> H H --> I[Titrate to euthyroidism]:::action I --> J[Phase 3: Long-term remission or definitive therapy]:::action J --> K{Remission achieved?}:::decision K -->|Yes| L[Continue antithyroid 12-18 months]:::action K -->|No| M[Consider radioiodine or surgery]:::action ``` ### Why This Answer Is Correct **High-Yield:** After 2 weeks on propranolol alone, the patient still has elevated free T4 and free T3 (both above normal range). Propranolol has reached its symptomatic benefit; an antithyroid drug is now essential to reduce hormone synthesis. **Timing of Antithyroid Initiation:** - Propranolol alone: 1–2 weeks for symptom relief - Add antithyroid drug: At the time of diagnosis or within 1–2 weeks if symptoms are severe - In this case: 2 weeks have passed; thyroid hormones remain elevated → antithyroid drug is overdue **Choice Between PTU and Methimazole:** | Feature | Methimazole | PTU | |---------|-------------|-----| | **First-line** | Yes (most patients) | Pregnancy, 1st trimester | | **Onset** | 4–6 weeks | 2–4 weeks (slightly faster) | | **Dose** | 30–40 mg daily | 300–450 mg TDS | | **Agranulocytosis risk** | ~0.1% | ~0.5% | | **Hepatotoxicity** | Rare | Rare but serious | | **Teratogenicity** | Methimazole embryopathy (rare) | None (preferred in pregnancy) | **Clinical Pearl:** In this non-pregnant male, methimazole is preferred (once-daily dosing, lower agranulocytosis risk). PTU is equally effective but reserved for pregnancy and first trimester due to teratogenicity risk with methimazole. ### Monitoring After Antithyroid Initiation 1. **TSH, free T4, free T3:** Every 4–6 weeks until euthyroid, then every 3 months 2. **Baseline CBC:** Before starting (especially PTU) 3. **Counsel on agranulocytosis:** Fever, sore throat, mouth ulcers → stop drug and seek urgent care [cite:Harrison 21e Ch 405; KD Tripathi 8e Ch 41] **Mnemonic: "BET on Antithyroid"** - **B**eta-blocker first (symptom relief) - **E**uthyroidism goal (add antithyroid drug) - **T**herapy: PTU or methimazole (hormone synthesis inhibition)
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.